Regular ArticlesInhibition of Vascular Endothelial Growth Factor (VEGF) Signaling in Cancer Causes Loss of Endothelial Fenestrations, Regression of Tumor Vessels, and Appearance of Basement Membrane Ghosts
Cited by (0)
Supported in part by the National Institutes of Health (grants HL-24136 and HL-59157 from the National, Heart, Lung, and Blood Institute and P50-CA90270 from the National Cancer Institute), Pfizer La Jolla Laboratories, and AngelWorks Foundation and the Vascular Mapping Project (to D.M.M.).
Competing interests statement: D.D.H. and D.R.S. are employed by Pfizer Global Research and Development and are holders of Pfizer company stock and stock options. G.T. and G.Y. are employed by Regeneron Pharmaceuticals and are holders of Regeneron stock and stock options.
Present address of T.I.: Department of Developmental Molecular Anatomy, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka 812-8582, Japan.
Copyright © 2004 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.